Загрузка...
Hematopoietic Progenitor Cell Mobilization with “Just-in-Time” Plerixafor Approach is a Cost Effective Alternative to Routine Plerixafor Use
Hematopoietic progenitor cell (HPC) mobilization with granulocyte-colony stimulating factor (G-CSF) and plerixafor results in superior CD34+ cell yield, when compared to mobilization with G-CSF alone in patients with myeloma and lymphoma. However, plerixafor-based approaches are associated with high...
Сохранить в:
| Опубликовано в: : | Cytotherapy |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4700501/ https://ncbi.nlm.nih.gov/pubmed/26475754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.09.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|